Posted by Ethan Ryder on Oct 10th, 2011
AstraZeneca announced today that they have upped their investment stake in China with the launch of a $200 million dollar manufacturing facility in the country.
The new plant will be in China Medical City (or, CMC), Taizhou, Jiangsu...
More of this article »